In this interactive panel of multidisciplinary experts including a dermatologist and two medical oncologists, discuss the rationale for immunotherapy in CSCC, a brief overview of mechanism of action of immunotherapy and impact on side effects as well as safety and efficacy of approved checkpoint inhibitors, and identifying patients who may benefit from immunotherapy.
Upon completion of this activity, participants should be better able to:
Associate Professor, Dermatology
Harvard Medical School
Director, Mohs and Dermatologic Surgery Center
Vice Chair, Surgical Oncology for the Department of Dermatology
Brigham and Women’s Faulkner Hospital/Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Associate Professor, Medical Oncology
University of Brescia
Brescia, Italy
Professor, Dermatology
Head, Dermato-oncology
Department of Dermatology
University of Kiel
Kiel, Germany
Professor, Dermatology
Head of the Oncodermatology Center
Dermatology Department
AP-HP Hôpital Saint Louis
Paris Diderot Université
INSERM U976
Paris, France
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
